STOCK TITAN

Dorman Products, Inc. (DORM) exec exercises options and sells 3,531 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bowen Gregory C., VP and Chief Accounting Officer of Dorman Products, reported exercising employee stock options for 3,531 shares of common stock on August 5, 2026 at exercise prices of $96.36 and $91.28 per share, then selling 3,531 shares at $145.23 and $144.72 per share. The related options vest in four equal annual installments beginning on March 2, 2023 and March 2, 2024.

Positive

  • None.

Negative

  • None.
Insider Bowen Gregory C.
Role VP, Chief Accounting Officer
Sold 3,531 shs ($512K)
Approx. gross sale proceeds $512K
Approx. exercise cost $332K
Approx. pre-tax spread $180K
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) F2 1,974 $0.00 $0.00
Exercise Employee Stock Option (right to buy) F3 1,557 $0.00 $0.00
Exercise Common Stock F1 1,974 $96.36 $190K
Exercise Common Stock 1,557 $91.28 $142K
Sale Common Stock 1,974 $145.23 $287K
Sale Common Stock 1,557 $144.72 $225K
Holdings After Transaction: Employee Stock Option (right to buy) — 520 shares (Direct); Common Stock — 5,340.4178 shares (Direct)
Footnotes (3)
  1. F1. The amount reported includes 62.075 shares acquired by the Reporting Person under Dorman's employee stock purchase plan on June 30, 2026.
  2. F2. The option vests in four equal annual installments beginning on March 2, 2023, which was the first anniversary of the date of grant.
  3. F3. The option vests in four equal annual installments beginning on March 2, 2024, which was the first anniversary of the date of grant.
Options exercised at $96.36 1974 shares Employee stock options converted to common stock on August 5, 2026 at $96.3600 exercise price
Options exercised at $91.28 1557 shares Employee stock options converted to common stock on August 5, 2026 at $91.2800 exercise price
Common shares sold at $145.23 1974 shares Common stock sale on August 5, 2026 at $145.2300 per share
Common shares sold at $144.72 1557 shares Common stock sale on August 5, 2026 at $144.7200 per share
Total option exercise shares 3531 shares Total employee stock option exercises reported on August 5, 2026
Total shares sold 3531 shares Aggregate Dorman Products common shares sold in the reported transactions
Employee stock purchase plan shares 62.075 shares Shares acquired under Dorman's employee stock purchase plan on June 30, 2026 per footnote
Employee Stock Option (right to buy) financial
"Security title listed as Employee Stock Option (right to buy) for derivative entries"
Exercise or conversion of derivative security financial
"Transaction code M is described as Exercise or conversion of derivative security"
Sale in open market or private transaction financial
"Transaction code S is described as Sale in open market or private transaction"
employee stock purchase plan financial
"Footnote notes 62.075 shares acquired under Dorman's employee stock purchase plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Section 16 of the Securities Exchange Act of 1934 regulatory
"Remarks reference Section 16 of the Securities Exchange Act of 1934"
A provision of federal securities law that requires company insiders—directors, officers and large shareholders—to publicly report their stock holdings and trades and to surrender any “short-swing” profits from purchases and sales within a six-month window. It acts like a rule that forces leaders to announce their trades and prevents quick buy-sell windfalls, giving investors transparency into insider activity and reducing opportunities for unfair gain.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did DORM's Bowen Gregory report on August 5, 2026?

On August 5, 2026, Bowen Gregory C. exercised employee stock options for 1,974 and 1,557 shares of Dorman Products common stock, then sold 1,974 shares at $145.23 and 1,557 shares at $144.72 per share in separate transactions.

How many DORM shares did Bowen Gregory sell and at what prices?

Bowen Gregory sold a total of 3,531 Dorman Products common shares: 1,974 shares at $145.23 per share and 1,557 shares at $144.72 per share, all dated August 5, 2026.

What stock options did Bowen Gregory exercise in Dorman Products (DORM)?

He exercised employee stock options covering 1,974 shares at an exercise price of $96.36 per share, expiring March 2, 2030, and 1,557 shares at $91.28 per share, expiring March 2, 2031, receiving an equal number of common shares.

How do the vesting schedules work for Bowen Gregory's DORM options?

A footnote states the 1,974-share option vests in four equal annual installments beginning March 2, 2023, and the 1,557-share option vests in four equal annual installments beginning March 2, 2024, each date being the first anniversary of its grant.

What does the Form 4 say about DORM's employee stock purchase plan?

A footnote notes that an amount reported includes 62.075 shares acquired by Bowen Gregory under Dorman's employee stock purchase plan on June 30, 2026, indicating participation in the company’s purchase plan alongside the option-related transactions.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bowen Gregory C.

(Last)(First)(Middle)
C/O DORMAN PRODUCTS, INC.
3400 EAST WALNUT STREET

(Street)
COLMAR PENNSYLVANIA 18915

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Dorman Products, Inc. [ DORM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP, Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/05/2026M1,974A$96.367,314.4178(1)D
Common Stock08/05/2026M1,557A$91.288,871.4178D
Common Stock08/05/2026S1,974D$145.236,897.4178D
Common Stock08/05/2026S1,557D$144.725,340.4178D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy)$96.3608/05/2026M1,974 (2)03/02/2030Common Stock1,974$00D
Employee Stock Option (right to buy)$91.2808/05/2026M1,557 (3)03/02/2031Common Stock1,557$0520D
Explanation of Responses:
1. The amount reported includes 62.075 shares acquired by the Reporting Person under Dorman's employee stock purchase plan on June 30, 2026.
2. The option vests in four equal annual installments beginning on March 2, 2023, which was the first anniversary of the date of grant.
3. The option vests in four equal annual installments beginning on March 2, 2024, which was the first anniversary of the date of grant.
Remarks:
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.
/s/ Frank J. Mahr, by Power of Attorney08/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)